Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy
Summary
Sun Pharma will acquire US-based Organon in a $12 billion deal, inheriting $8.6 billion debt and strengthening its specialty, biosimilars and women’s health p...
Description
Sun Pharma will acquire US-based Organon in a $12 billion deal, inheriting $8.6 billion debt and strengthening its specialty, biosimilars and women’s health p...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source